Listado de ensayos


Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Estado: | Categoría: | Resultado:

Patología

Non-exudative Age-related Macular Degeneration Diabetic Retinopathy Retina Vein Occlusion RETINOSIS PIGMENTARIA Hereditary Macular Degeneration

Tratamiento

Drug: CD34+ bone marrow stem cells intravitreal

Localizaciones

University of California Davis, Sacramento, California, United States
Ver informe

Advancing Understanding of Transportation Options

Estado: | Categoría: | Resultado:

Patología

Diabetic Retinopathy Macular Degeneration Glaucoma RETINOSIS PIGMENTARIA Vision Disorders Acute Coronary Syndrome Implantable Defibrillator User Congestive Heart Failure Hypertrophic Obstructive Cardiomyopathy Orthostatic Hypotension and 22 more

Tratamiento

Behavioral: Driving Decision Aid Behavioral: Older Drivers Website

Localizaciones

University of California, San Diego, La Jolla, California, United States CU Anschutz Medical Center, Aurora, Colorado, United States Indiana University, Indianapolis, Indiana, United States
Ver informe

Clinical and Genetic Examination of Usher Syndrome Patients’ Cohort in Europe

Estado: | Categoría: | Resultado:

Patología

Usher Syndrome

Localizaciones

CHU, Laboratoire de g n tique mol culaire, INSERM, Montpellier, France CIC of CHNO des Quinze-vingts, Paris, France Johannes Gutenberg University of Mainz, Institute of Zoology, Dept. Cell and Matrix Biology Mainz, Mainz, Germany Radboud University Nijmegen Medical Centre, Dept. Otorhinolaryngology, Nijmegen, Netherlands AIBILI, 4C - Coimbra Coordinating Centre for Clinical Research, Coimbra, Portugal IBILI- Faculty of Medicine - University of Coimbra, Center for Hereditary Diseases and Visual Neurosciences Laboratory, Coimbra, Portugal
Ver informe

A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

Estado: | Categoría: | Resultado:

Patología

Confirmed Biallelic RPE65 Mutation- associated Retinal Dystrophy

Tratamiento

Biological: AAV2-hRPE65v2,voretigene neparvovec-rzyl

Localizaciones

Children's Hospital of Los Angeles, Los Angeles, California, United States Bascom Palmer Eye Institute, Miami, Florida, United States University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States Massachusetts Eye and Ear Institute, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States Cincinnati Eye Institute, Cincinnati, Ohio, United States Casey Eye Institute, Portland, Oregon, United States Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States Scheie Eye Institute, Philadelphia, Pennsylvania, United States Cullen Eye Institute, Houston, Texas, United States
Ver informe

Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA Usher Syndrome Type 2 Usher Syndrome Type 3

Tratamiento

Drug: NT-501 Procedure: Sham

Localizaciones

University of California, San Francisco, San Francisco, California, United States
Ver informe

Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA Usher Syndromes

Tratamiento

Diagnostic Test: Whole Exome Sequencing

Localizaciones

Federal State Budgetary Institution "Moscow Helmholtz Research Institute of Eye Diseases" of the Ministry of Health, Moscow, Russian Federation Central Clinical Hospital under President Affairs, Moscow, Russian Federation
Ver informe

Treatment of RP and LCA by Primary RPE Transplantation

Estado: | Categoría: | Resultado:

Patología

Leber Congenital Amaurosis, RETINOSIS PIGMENTARIA

Tratamiento

Biological: Human primary Retinal Pigment Epithelial (HuRPE) cells

Localizaciones

Beijing Tongren Hospital, Beijing, China
Ver informe

Argus II Retinal Stimulation System Feasibility Protocol

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Argus II Retinal Stimulation System

Localizaciones

Doheny Eye Institute, Los Angeles, California, United States University of California San Francisco, San Francisco, California, United States Johns Hopkins, Wilmer Eye Institute, Baltimore, Maryland, United States Columbia University, Department of Ophthalmology, Edward S. Harkness Eye Institute, New York, New York, United States University of Pennsylvania, Scheie Eye Institute, Philadelphia, Pennsylvania, United States Wills Eye Hospital, Philadelphia, Pennsylvania, United States Retina Foundation of the Southwest, Dallas, Texas, United States Centre d'Investigation Clinique, Service d'Ophtalmologie, Quinze-Vingts National Eye Hospital, 28 rue de Charenton, 75557 Cedex 12, Paris, France Puerta de Hierro, Centro Medico, Centro de Retina, Zapopan, Jalisco, Mexico Clinique d'Ophthalmologie Hopitaux, Universitaires de Geneve 22 rue Alcide Jentzer 1205, Geneva, Switzerland Moorfields Eye Hospital, Vitreoretinal Research Unit, London, United Kingdom Manchester Royal Eye Hospital, Manchester, United Kingdom
Ver informe